Literature DB >> 139898

Hyperlipidaemia in patients with Down's syndrome.

Y Nishida, I Akaoka, T Nishizawa, M Maruki, K Maruki.   

Abstract

Plasma lipid levels were measured in 20 mongoloid and 16 non-mongoloid mentally retarded subjects. Significant elevations of plasma triglyceride levels were found in patients with Down's syndrome compared with mentally retarded controls. However, no significant difference was found in plasma cholesterol, phospholipid and free fatty acid levels between the mongoloids and control subjects.

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 139898     DOI： 10.1016/0021-9150(77)90090-9

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN： 0021-9150            Impact factor:   5.162


  5 in total

Review 1.  Cerebrovascular contributions to aging and Alzheimer's disease in Down syndrome.

Authors:  Donna M Wilcock; Frederick A Schmitt; Elizabeth Head
Journal:  Biochim Biophys Acta       Date:  2015-11-26

2.  New onset focal weakness in children with Down syndrome.

Authors:  Gordon Worley; Rolla Shbarou; Amy N Heffner; Karin M Belsito; George T Capone; Priya S Kishnani
Journal:  Am J Med Genet A       Date:  2004-07-01       Impact factor: 2.802

3.  Lipid profiles of children with Down syndrome compared with their siblings.

Authors:  Tahira Adelekan; Sheela Magge; Justine Shults; Virginia Stallings; Nicolas Stettler
Journal:  Pediatrics       Date:  2012-05-14       Impact factor: 7.124

4.  Sterol lipid metabolism in down syndrome revisited: down syndrome is associated with a selective reduction in serum brassicasterol levels.

Authors:  Gavin Tansley; Daniel T Holmes; Dieter Lütjohann; Elizabeth Head; Cheryl L Wellington
Journal:  Curr Gerontol Geriatr Res       Date:  2012-05-09

5.  Evaluation of biochemical and hematological parameters in adults with Down syndrome.

Authors:  David de Gonzalo-Calvo; Isabel Barroeta; Madalina Nicoleta Nan; José Rives; Diana Garzón; María Carmona-Iragui; Bessy Benejam; Laura Videla; Susana Fernández; Miren Altuna; Sílvia Valldeneu; Rafael Blesa; Alberto Lleó; Francisco Blanco-Vaca; Juan Fortea; Mireia Tondo
Journal:  Sci Rep       Date:  2020-08-13       Impact factor: 4.379
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.